The revisited immunophenotyping demonstrated the value of CD1a, cytoplasmatic CD3, CD5 and the inclusion of myeloid markers (CD117, CD11b, CD15), not previously included in other studies, in the identification of ETP-ALL cases. This evidence concerns the gene FUT4 and acute lymphoblastic leukemia.